We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+9.33%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$19.6B
AUM Growth
+$1.29B
Cap. Flow
+$10.1M
Cap. Flow %
0.05%
Top 10 Hldgs %
29.33%
Holding
681
New
30
Increased
359
Reduced
247
Closed
34

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$346M
2
ZTS icon
Zoetis
ZTS
+$215M
3
ATW
Atwood Oceanics
ATW
+$128M
4
MPC icon
Marathon Petroleum
MPC
+$126M
5
AGI icon
Alamos Gold
AGI
+$112M

Sector Composition

Rank Sector Weight
1 Materials 44.97%
2 Energy 26.85%
3 Industrials 4.46%
4 Healthcare 4.41%
5 Consumer Staples 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRC
101
DELISTED
DRESSER-RAND GROUP INC
DRC
$26.2M 0.13%
420,369
-94,154
-18% -$5.88M
RDC
102
DELISTED
Rowan Companies Plc
RDC
$25.1M 0.13%
684,684
-154,283
-18% -$5.54M
ANV
103
DELISTED
Allied Nevada Gold Corp
ANV
$24.9M 0.13%
5,947,296
-2,641,799
-31% -$13.8M
REGN icon
104
Regeneron Pharmaceuticals
REGN
$78.5B
$24.3M 0.12%
77,653
+16,910
+28% +$4.45M
JNJ icon
105
Johnson & Johnson
JNJ
$618B
$22.3M 0.11%
257,040
-47,766
-16% -$4.29M
ALXN
106
DELISTED
Alexion Pharmaceuticals
ALXN
$21.8M 0.11%
187,369
+29,451
+19% +$3.23M
TRX icon
107
TRX Gold Corp
TRX
$254M
$21.3M 0.11%
8,408,462
-6,436,401
-43% -$20.9M
ANDE icon
108
Andersons Inc
ANDE
$2.41B
$19.8M 0.1%
425,625
-65,687
-13% -$2.77M
BMRN icon
109
BioMarin Pharmaceuticals
BMRN
$11.6B
$19.5M 0.1%
270,840
+44,966
+20% +$2.99M
ONXX
110
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
$19.5M 0.1%
156,354
+7,121
+5% +$902K
ITC
111
DELISTED
ITC HOLDINGS CORP
ITC
$19.4M 0.1%
+620,799
New +$18.9M
SYY icon
112
Sysco
SYY
$40.8B
$19.1M 0.1%
601,308
+561,275
+1,402% +$18.8M
SE
113
DELISTED
Spectra Energy Corp Wi
SE
$19.1M 0.1%
558,852
+547,930
+5,017% +$18.9M
BEN icon
114
Franklin Resources
BEN
$17.6B
$19.1M 0.1%
376,903
+124,015
+49% +$5.99M
NVS icon
115
Novartis
NVS
$297B
$18.9M 0.1%
275,468
-12,932
-4% -$856K
TXN icon
116
Texas Instruments
TXN
$252B
$18.9M 0.1%
469,008
+5,090
+1% +$198K
EBAY icon
117
eBay
EBAY
$50.6B
$18.8M 0.1%
798,890
+226,483
+40% +$5.08M
GM.PRB
118
DELISTED
GENERAL MTRS CO JR PFD CONV SER B (DE)
GM.PRB
$18.6M 0.09%
371,726
-39,937
-10% -$1.99M
ILMN icon
119
Illumina
ILMN
$31B
$18.6M 0.09%
236,990
+39,172
+20% +$3M
KMI icon
120
Kinder Morgan
KMI
$71.7B
$18.5M 0.09%
519,055
+508,745
+4,934% +$19.1M
VEON icon
121
VEON
VEON
$3.62B
$18.4M 0.09%
62,591
-6,752
-10% -$1.8M
VRTX icon
122
Vertex Pharmaceuticals
VRTX
$121B
$18.4M 0.09%
242,435
+62,629
+35% +$4.98M
WW
123
DELISTED
WW International
WW
$18.4M 0.09%
491,795
+211,828
+76% +$8.53M
ORCL icon
124
Oracle
ORCL
$374B
$18.4M 0.09%
554,037
+191,999
+53% +$6.23M
WU icon
125
Western Union
WU
$1.98B
$18.3M 0.09%
981,989
+247,841
+34% +$4.45M

Similar funds

VanEck Associates's Q3 2013 Portfolio in Review

As of Q3 2013, VanEck Associates held 681 positions worth $19.6B, up 7.1% from $18.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

VanEck Associates's Q3 2013 filing shows 30 new, 359 increased, 247 reduced and 34 closed positions. Its largest new stake was Zoetis: 7,013,962 shares worth $218M. The largest sale was KUBOTA CORPORATION (ONE ADS REP 5 SHS COM), an estimated $255M.

By sector, the portfolio is most concentrated in Materials at 45% of assets, down from 45% a quarter earlier, followed by Energy and Industrials.

  • VanEck Associates's largest Q3 2013 buy was Zoetis: 7,013,962 shares worth $218M.
  • VanEck Associates added most to Franco-Nevada in Q3 2013, an estimated $346M increase.
  • VanEck Associates's biggest Q3 2013 reduction was Ensco Rowan plc, cutting an estimated $106M.
  • VanEck Associates fully exited KUBOTA CORPORATION (ONE ADS REP 5 SHS COM) in Q3 2013, selling an estimated $255M.
  • VanEck Associates's ten largest holdings make up 29% of its $19.6B portfolio in Q3 2013.
  • VanEck Associates opened 30 new positions and closed 34 in Q3 2013.
  • VanEck Associates's portfolio value rose 7.1% quarter-over-quarter to $19.6B.

Based on VanEck Associates's 13F filing for Q3 2013, filed 14 Nov 2013.